about
Hemoglobin-Based Blood Substitutes and the Treatment of Sickle Cell Disease: More Harm than Help?Oxidative pathways in the sickle cell and beyond.Haptoglobin: an emerging candidate for phenotypic modulation of sickle cell anemia?Mechanisms of Toxicity and Modulation of Hemoglobin-Based Oxygen Carriers (HBOCs).A common molecular signature of patients with sickle cell disease revealed by microarray meta-analysis and a genome-wide association study
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
HO-1 and CO: fighters vs sickle cell disease?
@en
HO-1 and CO: fighters vs sickle cell disease?
@nl
type
label
HO-1 and CO: fighters vs sickle cell disease?
@en
HO-1 and CO: fighters vs sickle cell disease?
@nl
prefLabel
HO-1 and CO: fighters vs sickle cell disease?
@en
HO-1 and CO: fighters vs sickle cell disease?
@nl
P2860
P1433
P1476
HO-1 and CO: fighters vs sickle cell disease?
@en
P2093
Jesus A Araujo
P2860
P304
P356
10.1182/BLOOD-2013-08-521922
P407
P577
2013-10-01T00:00:00Z